Tongyuan Acupuncture on Consciousness Disorder After Stroke

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Jan 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a special acupuncture technique called Tongyuan acupuncture on patients who have experienced a stroke and are facing difficulties with consciousness. After a stroke, some patients may have trouble staying awake or may not be fully aware of their surroundings, which can greatly affect their recovery and quality of life. Traditional treatments like medications and surgeries may not always be effective or can be invasive and costly. This trial aims to see if Tongyuan acupuncture can provide a safe, effective, and easier way to help improve consciousness in stroke survivors.

To participate in this trial, individuals should be between 18 and 85 years old, have had a stroke within the last six months, and have specific scores indicating their level of consciousness. They also need to be in stable condition and not participating in other clinical studies at the same time. Participants will receive Tongyuan acupuncture and will be monitored to see how it affects their consciousness. This trial hopes to offer a new treatment option that is both accessible and beneficial for those recovering from stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. sign the informed consent voluntarily;
• • 2. met the above diagnostic criteria, and the GCS score was between 3 and 9 (the score was scored by a rehabilitation physician, and the patient had not used sedatives or anesthetics on the day of the score);
• • 3. The patient's condition is stable, vital signs are stable, and the onset time of consciousness disturbance caused by stroke is confirmed to be less than 6 months;
• • 4. Cerebral infarction or cerebral hemorrhage confirmed by clinical and auxiliary examination is the only factor causing consciousness disorder, excluding other diseases caused consciousness disorder patients;
• • 5. those aged between 18 and 85;
• • 6. Family members or authorized principals know and sign informed consent;
• • 7. did not enter other clinical studies at the same time.
• Exclusion Criteria:
• • 1. People with consciousness impairment mainly due to changes in consciousness content or special types;
• • 2. confirmed carbon monoxide poisoning, brain tumor, brain trauma, brain parasitic disease, metabolic disorders;
• • 3. Patients with severe primary diseases of liver, kidney, blood system, endocrine system and other diseases with poor prognosis, mental diseases;
• • 4. have upper gastrointestinal hemorrhage, secondary epilepsy and other serious complications;
• • 5. Those who have venous thrombosis and are currently on anticoagulant therapy;
• • 6. patients judged by the investigator to be unsuitable for participation in this trial;